Language differences are among the most persistent patient recruitment challenges in community-based clinical research.
Potential participants must understand why a study is being conducted, what participation involves, how often they will need to attend visits, and what will happen during the screening process. When this information is delivered in unfamiliar or highly technical language, uncertainty can quickly become disengagement.
For pharmaceutical sponsors and CROs, multilingual communication is therefore not only a translation task. It is part of building trust, improving access, supporting enrollment, and helping participants remain engaged throughout the study.
Effective outreach combines translated campaigns with approachable communication, specialized patient support, community awareness, and continued guidance from initial interest through study completion.
Why Language Creates Patient Recruitment Challenges
Clinical trial protocols can be difficult to understand even when patients and research teams speak the same language.
Eligibility criteria, medical terminology, study procedures, visit schedules, privacy requirements, and potential risks can create confusion. When a person is communicating in a second language, they may feel less comfortable asking questions or explaining their concerns.
These patient recruitment challenges can appear at several stages. A patient may respond to an advertisement but stop before prescreening. Another may schedule a visit but fail to attend because the instructions were unclear. Some may distrust the process because the communication feels overly formal or disconnected from their normal healthcare experience.
Language can also affect how patients discuss participation with family members or caregivers. In many communities, healthcare decisions are not made individually. Patients may need clear information they can confidently share with the people involved in their care.
Addressing language barriers in healthcare therefore requires communication that is accurate, accessible, respectful, and close to the way people speak in daily life.
Translation Alone Is Not Enough
Multilingual recruitment often begins with English and Spanish, but an effective strategy should be able to adapt to the languages and communication preferences of each patient population.
Translated advertising and patient-facing materials can make a study more accessible. However, using the same message in another language does not automatically make it relevant or understandable.
Addressing these patient recruitment challenges requires direct communication, cultural awareness, and continued patient guidance.
The tone of the message may need to change. The most effective communication channel may also vary by community. Some patients may respond more comfortably to a phone call, while others prefer text messages, email, or communication through their healthcare provider.
A multilingual strategy should preserve the meaning and accuracy of the study information while making the message feel approachable. Patients need enough space to ask questions, explain concerns, and understand what will happen next.
This is the difference between basic translation and meaningful multilingual community engagement.
Community-Based Outreach Can Improve Trust
Community-based healthcare outreach introduces research through settings and relationships that are already familiar to patients.
Instead of relying exclusively on national advertising or unfamiliar recruitment centers, sponsors can connect studies with community clinics, physicians, local referral networks, and targeted digital campaigns.
Community relationships can help reduce patient recruitment challenges by making research communication feel more relevant and trustworthy.
This does not mean assuming that every person within a community has the same preferences. It means creating a flexible outreach strategy that responds to the language, culture, location, and communication habits of the people the study is intended to reach.
The FDA’s final guidance on enhancing participation in clinical trials recommends approaches intended to increase the enrollment of populations that more accurately represent the patients likely to use an approved treatment.
Reaching diverse patient populations requires more than opening a site in a diverse location. Patients also need clear messages, accessible support, responsive follow-up, and a realistic path from initial interest to participation.
Patients Need a Guided Recruitment Journey
One of the most important patient recruitment challenges occurs after a person responds to a campaign.
Interest can quickly disappear when an inquiry is not answered promptly, the next step is unclear, or the patient must repeat the same information to several disconnected teams.
A coordinated process should guide the patient through initial contact, prescreening, scheduling, visit preparation, reminders, and follow-up.
A specialized team can first review the protocol’s inclusion requirements and determine how to communicate the opportunity to relevant patient populations. Different specialists may then support eligibility questions, scheduling, patient education, and site coordination.
The goal is not to remove every handoff. It is to make sure those handoffs do not feel fragmented to the patient.
A potential participant should know who is contacting them, why information is being requested, what will happen during the next step, and who can answer additional questions. This consistency helps patients feel guided rather than passed between departments.
Retention Begins During Recruitment
These patient recruitment challenges do not end once a participant enrolls.
A recent analysis of 90 trials involving 86,107 participants found an overall attrition rate of 16.9%, although the rate varied considerably between studies. This demonstrates why participant retention must be considered throughout the patient journey.
Patients may leave a study for medical or personal reasons that cannot be prevented. However, unclear expectations, communication gaps, missed reminders, scheduling difficulties, and limited support can also contribute to disengagement.
Retention should therefore begin during the first conversation.
Patients should understand the expected study duration, visit frequency, procedures, time commitment, and available support before they decide to participate. After enrollment, reminders, scheduling assistance, follow-up, preferred communication channels, and permitted participant compensation or practical support can help make continued participation more manageable.
The objective is never to pressure someone to remain in a study. Participation must remain voluntary. The objective is to remove avoidable confusion and ensure that participants feel informed, respected, and supported.
Technology Should Strengthen Human Support
Technology can improve clinical trial recruitment when it connects people and processes instead of replacing personal communication.
Multilingual digital campaigns can expand reach. Centralized platforms can help teams respond to inquiries, monitor prescreening, coordinate appointments, send reminders, and track where potential participants disengage.
Technology can also allow recruitment specialists, site teams, patient engagement personnel, and other departments to work from a connected patient journey.
This coordination is especially important when several specialists support the same participant. Shared visibility helps reduce missed follow-ups, unnecessary repetition, and inconsistent instructions.
The most valuable technology is not necessarily the platform with the most features. It is the technology that helps teams communicate more effectively and gives patients a clearer, smoother experience.
How FOMAT Approaches Multilingual Recruitment
FOMAT uses multilingual advertising, community campaigns, patient-facing communication, prescreening, scheduling, reminders, and continued follow-up to support potential participants throughout recruitment.
English and Spanish form an important part of this work, while outreach can also be adapted to additional languages and the needs of different communities.
A specialized team reviews inclusion requirements and determines how the study should be presented to relevant patient populations. The tone, channel, and outreach strategy can then be adjusted based on the community and patient journey.
FOMAT’s Patient Recruitment Excellence approach connects patient identification, multilingual engagement, scheduling, and follow-up with the operations of participating research sites.
Its broader work in diversity in clinical trials focuses on expanding access through community relationships, localized outreach, and support for populations that have historically faced barriers to research participation.
FOMAT reports a 76% diverse enrollment rate and approximately 90% participant retention across its work. These results reflect an ongoing effort to improve outreach, communication, technology, and the overall patient experience.
That work was recognized with the 2024 SCRS Excellence in Patient Centricity Award.
FOMAT continues exploring tools that improve patient reach and allow specialists across departments to work together. This coordination is part of its embedded research model, which connects clinical trials with the physicians, clinics, and communities where patients already receive care.
Creating a More Accessible Recruitment Experience
Solving patient recruitment challenges requires more than translating an advertisement.
Sponsors and CROs need a connected strategy that combines multilingual communication, community-based outreach, approachable education, responsive follow-up, and continued participant support.
Patients are more likely to engage when they understand the opportunity, trust the people communicating with them, and know what to expect at every stage.
By designing recruitment around the patient experience, research teams can expand access, strengthen enrollment, and build the consistent communication needed to support retention from the first contact through the final study visit.